InvestIn10

InvestIn10 Updated 

-- price has sustained above 20 DMA during the market correction. -- high Del% -- At RS support. Continuation in stage 2 up-move should happen. Sideways move will nullify the RS support line.

InvestIn10 Updated 

-- price has sustained above 50 DMA during the market correction. Stage breakout. -- high Del% -- RS consolidation breakout. At RS support line. -- Big company when moves with momentum it usually sustains the same -> stay invested.

InvestIn10 Updated 

NSE:HIKAL - RS breakout from the previous consolidation. - High RS (1.22) - at fib 0.382 - Pharma Index getting strong - R/R = 6

InvestIn10 Updated 

- R/R = 3 - AVWAP resistance at 2214 - RS +ve and trending up. - Pharma index getting stronger

InvestIn10 Updated 

NSE:CIPLA R/R = 4.63 Good volume move 26 Nov. RS -ve, RS yet to breakout from purple box, but most likely will breakout. Pharma heavyweight. will surely move if Pharma Index further improves.

InvestIn10 Updated 

- It was a good R/R trade earlier but it went against expectation. - AVWAP giving strong resistance and its become a sell on RISE trade. - RS triangle is converging, there is a chance that downward sloping RS line might get hit, that would be the chance to exit. - RS still at support. Hospitals are in good favor. - Risk was set high due to the high volatility.

InvestIn10 Updated 

- sitting quietly on 200 dma - volumes not yet there, might see another short dip - low risk trade, can get shaken out if the correction is deep. - trade taken due to pharma index getting strong. - wait and watch.

InvestIn10 Updated 

- top down analysis trade, based on strength of IT index

InvestIn10

-- very bullish setup -- price has sustained above 20 DMA during the market correction. -- high Del% -- stage breakout on both Price and RS charts.

InvestIn10

Fundamentals: - One of the cheapest Pharma stock (PE 10) - Zero Debt. Clean Balance Sheet. Good cash reserves. - Well known Promoter family. - OrbiMed backing Techincals: - Limited downside from these levels. - At fib 0.5 - Pharma Index on the recovery path - channel support Take your own risk. Disclaimer: invested.

InvestIn10

- top down analysis trade, based on strength of IT index